IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 31 filers reported holding IMMUCELL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 27 | -88.8% | 0.00% | – |
| Q2 2023 | $1,000 | – | 241 | +173.9% | 0.00% | – |
| Q3 2020 | $0 | – | 88 | +8700.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
| Q3 2017 | $3,000 | -25.0% | 501 | +0.2% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -42.9% | 500 | -50.0% | 0.00% | – |
| Q2 2016 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |